Pascall Systems
Pascall Systems, a groundbreaking precision EEE-guided anesthesia management platform, aims to reduce oversedation to improve postoperative outcomes, such as preventing postoperative delirium (POD) and opioid dependence. The company's first innovation, the Wireless EEG system (M0 SYSTEM), achieved FDA 510(k)-clearance in 2022. The company is focusing on developing its next-gen M1 SYSTEM, gathering crucial clinical data (at MGH/Stanford).
Contact Name:
Tuan Le Mau
Contact Email:
Website:
https://www.pascallsystems.com/
City, State – Congressional District:
Boston,
MA
–
8
Technology:
Platform
Funding:
Aging (NIA),
Drug Abuse (NIDA),
Neurological Disorders and Stroke (NINDS)
NIH Projects:
NIH RePorter for
Pascall Systems
Sponsored Event(s):
The MedTech Conference | 2024
